Indaptus Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
13.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-1.12
|
0.00
|
1.12
|
100.00%
|
|
2022-12-31
|
-0.38
|
0.00
|
0.38
|
100.00%
|
|
2022-09-30
|
-0.53
|
-0.42
|
0.11
|
20.75%
|
|
2022-06-30
|
-0.48
|
-0.46
|
0.02
|
4.17%
|
|
2022-03-31
|
-0.83
|
-0.41
|
0.42
|
50.60%
|
|
2021-12-31
|
-0.90
|
-0.22
|
0.68
|
75.56%
|
|
2021-09-30
|
-0.55
|
-0.81
|
-0.26
|
-47.27%
|
|
2021-06-30
|
-2.56
|
-5.53
|
-2.97
|
-116.02%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.29
|
|
2021-12-31
|
-10.40
|
|
2020-12-31
|
-16.32
|
|
2019-12-31
|
-93.60
|
|
2018-12-31
|
-8.43
|
|
2017-12-31
|
-1.57
|
|
2016-12-31
|
-4.48
|
|
2015-12-31
|
-41.48
|
|
2014-12-31
|
-1.90
|
|
2013-12-31
|
-2.00
|
|
2012-12-31
|
-0.37
|